387464001: Phenylpropanolamine (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\Autonomic agent (substance)\Sympathomimetic agent (substance)\Phenylpropanolamine
\Drug or medicament (substance)\Respiratory system agent (substance)\Cough/decongestant preparation\Decongestant\Phenylpropanolamine

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Amine\Amino alcohol (substance)\Alkanolamine (substance)\Propanolamine (substance)\Phenylpropanolamine

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Amine\Amino alcohol (substance)\Alkanolamine (substance)\Propanolamine (substance)\Phenylpropanolamine
\Organic compound\Substance with alcohol structure (substance)\Amino alcohol (substance)\Alkanolamine (substance)\Propanolamine (substance)\Phenylpropanolamine

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Phenylpropanolamine	Is a	Sympathomimetic agent (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Phenylpropanolamine	Is a	Decongestant	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Phenylpropanolamine	Is a	Propanolamine (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Phenylpropanolamine measurement	Component	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Brompheniramine maleate+dextromethorphan hydrobromide+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Phenylpropanolamine hydrochl 75mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Phenylpropanolamine hydrochloride	Is a	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Clemastine+phenylpropanolamine 0.5/25mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing clemastine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing clemastine fumarate and paracetamol and phenylpropanolamine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Chlorphenamine- and paracetamol- and phenylpropanolamine-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing chlorphenamine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing guaifenesin and phenylephrine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing guaifenesin and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing hydrocodone and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Phenylpropanolamine + carmiphen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Brompheniramine maleate + phenylpropanolamine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Brompheniramine maleate + phenylephrine+ phenylpropanolamine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Phenylpropanolamine hydrochl 75mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Phenylpropanolamine hydrochl 75mg capsule	Has basis of strength substance (attribute)	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet	Has basis of strength substance (attribute)	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet	Has basis of strength substance (attribute)	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Chlorphenamine maleate 4 mg and mepyramine maleate 25 mg and phenylephrine hydrochloride 10 mg and phenylpropanolamine 50 mg oral tablet	Has basis of strength substance (attribute)	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Chlorphenamine maleate 4 mg and mepyramine maleate 25 mg and phenylephrine hydrochloride 10 mg and phenylpropanolamine 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	4
Chlorphenamine maleate 4 mg and mepyramine maleate 25 mg and phenylephrine hydrochloride 10 mg and phenylpropanolamine 50 mg oral tablet	Has basis of strength substance (attribute)	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	4
Phenylpropanolamine hydrochloride	Is modification of (attribute)	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet	Has precise active ingredient	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Chlorphenamine maleate 4 mg and mepyramine maleate 25 mg and phenylephrine hydrochloride 10 mg and phenylpropanolamine 50 mg oral tablet	Has precise active ingredient	False	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Clemastine- and phenylpropanolamine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	4
Product containing chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	4
Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Phenylpropanolamine hydrochl 75mg capsule	Has precise active ingredient	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing phenylpropanolamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Allergy to phenylpropanolamine (finding)	Causative agent (attribute)	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only chlorphenamine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Clemastine and paracetamol and phenylpropanolamine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only clemastine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	4
Product containing only chlorphenamine and paracetamol and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Hydrocodone and phenylpropanolamine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Guaifenesin and phenylephrine and phenylpropanolamine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Guaifenesin and phenylpropanolamine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Clemastine and phenylpropanolamine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Clemastine and paracetamol and phenylpropanolamine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	4
Phenylpropanolamine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only brompheniramine and codeine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing brompheniramine and codeine and phenylpropanolamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing brompheniramine and codeine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing only brompheniramine and codeine and phenylpropanolamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely clemastine fumarate 670 microgram and phenylpropanolamine 25 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely clemastine fumarate 670 microgram and phenylpropanolamine 25 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Adverse reaction to phenylpropanolamine	Causative agent (attribute)	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Chlorphenamine maleate 4 mg and mepyramine maleate 25 mg and phenylephrine hydrochloride 10 mg and phenylpropanolamine 50 mg oral tablet	Has basis of strength substance (attribute)	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Chlorphenamine maleate 4 mg and mepyramine maleate 25 mg and phenylephrine hydrochloride 10 mg and phenylpropanolamine 50 mg oral tablet	Has precise active ingredient	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Clemastine fumarate 0.335mg/phenylpropanolamine hydrochloride 30mg/acetaminophen 500mg tablet	Has precise active ingredient	True	Phenylpropanolamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461642010	Phenylpropanolamine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481555013	Phenylpropanolamine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1461642010	Phenylpropanolamine (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1461642010	Phenylpropanolamine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481555013	Phenylpropanolamine	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1481555013	Phenylpropanolamine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
833251000172115	phénylpropanolamine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
833251000172115	phénylpropanolamine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module